CPS: Synergy: Sensor Network-Based Lower-Limb Prosthetic Optimization and Control

CPS:协同:基于传感器网络的下肢假肢优化和控制

基本信息

  • 批准号:
    1552163
  • 负责人:
  • 金额:
    $ 90.19万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
    Standard Grant
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-05-16 至 2020-11-30
  • 项目状态:
    已结题

项目摘要

More than one million people including many wounded warfighters from recent military missions are living with lower-limb amputation in the United States. This project will design wearable body area sensor systems for real-time measurement of amputee's energy expenditure and will develop computer algorithms for automatic lower-limb prosthesis optimization. The developed technology will offer a practical tool for the optimal prosthetic tuning that may maximally reduce amputee's energy expenditure during walking. Further, this project will develop user-control technology to support user's volitional control of lower-limb prostheses. The developed volitional control technology will allow the prosthesis to be adaptive to altered environments and situations such that amputees can walk as using their own biological limbs. An optimized prosthesis with user-control capability will increase equal force distribution on the intact and prosthetic limbs and decrease the risk of damage to the intact limb from the musculoskeletal imbalance or pathologies. Maintenance of health in these areas is essential for the amputee's quality of life and well-being. Student participation is supported.This research will advance Cyber-Physical Systems (CPS) science and engineering through the integration of sensor and computational technologies for the optimization and control of physical systems. This project will design body area sensor network systems which integrate spatiotemporal information from electromyography (EMG), electroencephalography (EEG) and inertia measurement unit (IMU) sensors, providing quantitative, real-time measurements of the user's physical load and mental effort for personalized prosthesis optimization. This project will design machine learning technology-based, automatic prosthesis parameter optimization technology to support in-home prosthesis optimization by users themselves. This project will also develop an EEG-based, embedded computing-supported volitional control technology to support user?s volitional control of a prosthesis in real-time by their thoughts to cope with altered situations and environments. The technical advances from this project will provide wearable and wireless body area sensing solutions for broader applications in healthcare and human-CPS interaction applications. The explored computational methods will be broadly applicable for real-time, automatic target recognition from spatiotemporal, multivariate data in CPS-related communication and control applications. This synergic project will be implemented under multidisciplinary team collaboration among computer scientists and engineers, clinicians and prosthetic industry engineers. This project will also provide interdisciplinary, CPS relevant training for both undergraduate and graduate students by integrating computational methods with sensor network, embedded processors, human physical and mental activity recognition, and prosthetic control.
在美国,有超过一百万人,包括许多在最近的军事任务中受伤的战士,生活在下肢截肢的情况下。本计画将设计可穿戴式人体面积感测器系统,以即时量测截肢者的能量消耗,并将发展电脑演算法,以自动化下肢义肢的最佳化。这项技术将为假肢的优化调整提供一个实用的工具,可以最大限度地减少截肢者在行走过程中的能量消耗。此外,本计画将发展使用者控制技术,以支援使用者对下肢义肢的意志控制。开发的意志控制技术将使假肢能够适应改变的环境和情况,使截肢者能够使用自己的生物肢体行走。具有用户控制能力的优化假肢将增加完好肢体和假肢上的相等力分布,并降低肌肉骨骼失衡或病理对完好肢体造成损伤的风险。保持这些区域的健康对截肢者的生活质量和福祉至关重要。 这项研究将通过传感器和计算技术的集成来优化和控制物理系统,从而推进网络物理系统(CPS)科学和工程。该项目将设计身体区域传感器网络系统,该系统集成来自肌电图(EMG),脑电图(EEG)和惯性测量单元(IMU)传感器的时空信息,为个性化假肢优化提供定量,实时测量用户的身体负荷和精神努力。本项目将设计基于机器学习技术的假肢参数自动优化技术,支持用户自行进行家庭假肢优化。本计画亦将发展一种以脑电为基础,以嵌入式计算为支援的意志控制技术,以支援使用者?他们的意志控制的假肢实时通过他们的思想,以科普变化的情况和环境。该项目的技术进步将为医疗保健和人类CPS交互应用中的更广泛应用提供可穿戴和无线身体区域传感解决方案。探索的计算方法将广泛适用于实时,自动目标识别的时空,多变量数据在CPS相关的通信和控制应用。这个协同项目将在计算机科学家和工程师、临床医生和假肢行业工程师之间的多学科团队合作下实施。该项目还将为本科生和研究生提供跨学科的CPS相关培训,将计算方法与传感器网络,嵌入式处理器,人类身心活动识别和假肢控制相结合。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ou Bai其他文献

Time to Lymphoma Treatment within 24 Months in Watchful Waiting Follicular Lymphoma Defines Patients at High Risk for Progression: A Multicenter Analysis
  • DOI:
    10.1182/blood-2023-174308
  • 发表时间:
    2023-11-02
  • 期刊:
  • 影响因子:
  • 作者:
    Fenghua Gao;Jing Liu;Jiesong Wang;Lihong Liu;Zhiming Li;Yuqin Song;Xudong Zhang;Hui Zhou;Xiuhua Sun;Wei Zhang;Bing Xu;Liping Su;Wen Shujuan;Rong Tao;Ou Bai;Qingyuan Zhang;Liqun Zou;Xianhuo Wang;Huilai Zhang
  • 通讯作者:
    Huilai Zhang
FFA Promoting Proliferation and Migration Via Classical Wnt Signaling Pathway in Peripheral T Cell Lymphoma
  • DOI:
    10.1182/blood-2022-170462
  • 发表时间:
    2022-11-15
  • 期刊:
  • 影响因子:
  • 作者:
    Wei Guo;Xingtong Wang;Chunshui Liu;Yan Li;Ou Bai
  • 通讯作者:
    Ou Bai
C-Terminal Pro-Gly-Pro Tripeptide in Contrast to Full-Length Neuropeptide Semax Exhibits No Neuroprotective Effect in Experimental Cerebral Ischemia
  • DOI:
    10.1007/s10517-005-0311-5
  • 发表时间:
    2005-04-01
  • 期刊:
  • 影响因子:
    0.600
  • 作者:
    O. E. Fadyukova;A. Kadi;Ou Bai;G. M. Andzhusheva;V. B. Koshelev
  • 通讯作者:
    V. B. Koshelev
Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China
  • DOI:
    10.1186/s13045-017-0439-6
  • 发表时间:
    2017-03-15
  • 期刊:
  • 影响因子:
    40.400
  • 作者:
    Yuankai Shi;Bo Jia;Wei Xu;Wenyu Li;Ting Liu;Peng Liu;Weili Zhao;Huilai Zhang;Xiuhua Sun;Haiyan Yang;Xi Zhang;Jie Jin;Zhengming Jin;Zhiming Li;Lugui Qiu;Mei Dong;Xiaobing Huang;Yi Luo;Xiaodong Wang;Xin Wang;Jianqiu Wu;Jingyan Xu;Pingyong Yi;Jianfeng Zhou;Hongming He;Lin Liu;Jianzhen Shen;Xiaoqiong Tang;Jinghua Wang;Jianmin Yang;Qingshu Zeng;Zhihui Zhang;Zhen Cai;Xiequn Chen;Kaiyang Ding;Ming Hou;Huiqiang Huang;Xiaoling Li;Rong Liang;Qifa Liu;Yuqin Song;Hang Su;Yuhuan Gao;Lihong Liu;Jianmin Luo;Liping Su;Zimin Sun;Huo Tan;Huaqing Wang;Jingwen Wang;Shuye Wang;Hongyu Zhang;Xiaohong Zhang;Daobin Zhou;Ou Bai;Gang Wu;Liling Zhang;Yizhuo Zhang
  • 通讯作者:
    Yizhuo Zhang
Efficacy and safety of MIL62, a novel glycoengineered type Ⅱ anti-CD20 monoclonal antibody, combined with lenalidomide in patients with relapsed/refractory follicular lymphoma or marginal zone lymphoma: a multicentre, single-arm, phase 1b/2 trial
新型糖工程Ⅱ型抗CD20单克隆抗体MIL62联合来那度胺治疗复发/难治性滤泡性淋巴瘤或边缘区淋巴瘤的疗效和安全性:多中心、单臂、1b/2期试验
  • DOI:
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    15.1
  • 作者:
    Yuankai Shi;K. Zhou;Hui Zhou;Yan Qin;Hongmei Jing;Ying Xiang;Zhao Wang;Zhen Wang;Aimin Zang;Ou Bai;Zhenyu Li;Huilai Zhang;Yongping Song;Jinjin Liang;Min Wei
  • 通讯作者:
    Min Wei

Ou Bai的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ou Bai', 18)}}的其他基金

SCC-PG: Closed-loop Intervention to Promote a Supportive and Interactive Environment around Children
SCC-PG:闭环干预,促进儿童周围的支持性和互动环境
  • 批准号:
    2125549
  • 财政年份:
    2021
  • 资助金额:
    $ 90.19万
  • 项目类别:
    Standard Grant
I-Corps: Mobile, Smart Gait Assessment System
I-Corps:移动智能步态评估系统
  • 批准号:
    1849087
  • 财政年份:
    2018
  • 资助金额:
    $ 90.19万
  • 项目类别:
    Standard Grant
I-Corps: Automatic Tuning for Prosthesis Based on Physiological Feedback
I-Corps:基于生理反馈的假肢自动调节
  • 批准号:
    1745597
  • 财政年份:
    2017
  • 资助金额:
    $ 90.19万
  • 项目类别:
    Standard Grant
CPS: Synergy: Sensor Network-Based Lower-Limb Prosthetic Optimization and Control
CPS:协同:基于传感器网络的下肢假肢优化和控制
  • 批准号:
    1446737
  • 财政年份:
    2014
  • 资助金额:
    $ 90.19万
  • 项目类别:
    Standard Grant

相似海外基金

Leveraging the synergy between experiment and computation to understand the origins of chalcogen bonding
利用实验和计算之间的协同作用来了解硫族键合的起源
  • 批准号:
    EP/Y00244X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 90.19万
  • 项目类别:
    Research Grant
Multiple Representations of Learning in Dynamics and Control: Exploring the Synergy of Low-Cost Portable Lab Equipment, Virtual Labs, and AI within Student Learning Activities
动力学和控制中学习的多重表示:探索低成本便携式实验室设备、虚拟实验室和人工智能在学生学习活动中的协同作用
  • 批准号:
    2336998
  • 财政年份:
    2024
  • 资助金额:
    $ 90.19万
  • 项目类别:
    Standard Grant
Development of a novel oral vaccine for fish: Synergy of chitosan nano particle and complement-mediated opsonization
新型鱼类口服疫苗的开发:壳聚糖纳米颗粒与补体介导的调理作用的协同作用
  • 批准号:
    24K17960
  • 财政年份:
    2024
  • 资助金额:
    $ 90.19万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Synergy between future 21-cm experiments and physical cosmology
未来 21 厘米实验与物理宇宙学之间的协同作用
  • 批准号:
    DE240101129
  • 财政年份:
    2024
  • 资助金额:
    $ 90.19万
  • 项目类别:
    Discovery Early Career Researcher Award
Investigation of upper limb synergy in hemiplegic patients and development of neurorehabilitation.
偏瘫患者上肢协同作用的调查和神经康复的发展。
  • 批准号:
    23K10410
  • 财政年份:
    2023
  • 资助金额:
    $ 90.19万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
BRITE Synergy: Chemically Resilient, Fouling Resistant Separation Membranes Manufactured Using Aqueous Phase Inversion
BRITE Synergy:采用水相转化技术制造的化学弹性、防污分离膜
  • 批准号:
    2227307
  • 财政年份:
    2023
  • 资助金额:
    $ 90.19万
  • 项目类别:
    Standard Grant
Contralesional Corticobulbospinal Structural and Functional Changes Post Stroke: Biomarkers for the upper limb flexion synergy
中风后对侧皮质球脊髓结构和功能变化:上肢屈曲协同作用的生物标志物
  • 批准号:
    10741103
  • 财政年份:
    2023
  • 资助金额:
    $ 90.19万
  • 项目类别:
BRITE Synergy: Seismic Cracking of Embankments and Earth Dams
BRITE Synergy:路堤和土坝的地震开裂
  • 批准号:
    2226154
  • 财政年份:
    2023
  • 资助金额:
    $ 90.19万
  • 项目类别:
    Standard Grant
Mechanisms of Synergy between Oncolytic Herpes Simplex Virus and Trabectedin in Pediatric Bone Sarcomas
溶瘤单纯疱疹病毒与曲贝替定治疗小儿骨肉瘤的协同作用机制
  • 批准号:
    10607503
  • 财政年份:
    2023
  • 资助金额:
    $ 90.19万
  • 项目类别:
Sex-dependent synergy between O3 exposure, APOE4 e4 genotype, and aging in the onset of Alzheimer's disease
O3 暴露、APOE4 e4 基因型和衰老在阿尔茨海默病发病过程中的性别依赖性协同作用
  • 批准号:
    10584765
  • 财政年份:
    2023
  • 资助金额:
    $ 90.19万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了